These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5443882)

  • 1. The influence of various neuroleptic drugs on shock avoidance responding in rats. 3. Amphetamine antagonism in the discriminated Sidman avoidance procedure.
    Niemegeers CJ; Verbruggen FJ; Janssen PA
    Psychopharmacologia; 1970; 17(2):151-9. PubMed ID: 5443882
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of various neuroleptic drugs on shock avoidance responding in rats. I. Nondiscriminated Sidman avoidance procedure.
    Niemegeers CJ; Verbruggen FJ; Janssen PA
    Psychopharmacologia; 1969; 16(3):161-74. PubMed ID: 5364169
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of various neuroleptic drugs on shock avoidance responding in rats. II. Nondiscriminated Sidman avoidance procedure with alternate reinforcement and extinction periods and analysis of the interresponse times (IRT's).
    Niemegeers CJ; Verbruggen FJ; Janssen PA
    Psychopharmacologia; 1969; 16(3):175-82. PubMed ID: 5391696
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of various neuroleptic drugs on noise escape response in rats.
    Niemegeers CJ; Verbruggen FJ; Janssen PA
    Psychopharmacologia; 1970; 18(3):249-59. PubMed ID: 5530581
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuropharmacologic analysis of AHR-2277 a new psychotherapeutic agent.
    Johnson DN; Funderburk WH; Ward JW
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):197-208. PubMed ID: 5123867
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of psychotropic agents on Sidman avoidance response in good- and poor-performing rats.
    Takaori S; Yada N; Mori G
    Jpn J Pharmacol; 1969 Dec; 19(4):587-96. PubMed ID: 5308406
    [No Abstract]   [Full Text] [Related]  

  • 7. [Phenamine antagonism as a treat for experimental evaluation of neuroleptics].
    Raevskiĭ KS
    Farmakol Toksikol; 1973; 36(2):149-54. PubMed ID: 4151668
    [No Abstract]   [Full Text] [Related]  

  • 8. The distribution of the butyrophenones haloperidol, trifluperidol, moperone, and clofluperol in rats, and its relationship with their neuroleptic activity.
    Janssen PA; Allewijn FT
    Arzneimittelforschung; 1969 Feb; 19(2):199-208. PubMed ID: 5818759
    [No Abstract]   [Full Text] [Related]  

  • 9. Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidol.
    Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1974 Jan; 24(1):45-52. PubMed ID: 4406109
    [No Abstract]   [Full Text] [Related]  

  • 10. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
    Janssen PA; Niemegeers CJ; Schellekens KH; Dresse A; Lenaerts FM; Pinchard A; Schaper WK; van Nueten JM; Verbruggen FJ
    Arzneimittelforschung; 1968 Mar; 18(3):261-79. PubMed ID: 4386815
    [No Abstract]   [Full Text] [Related]  

  • 11. Antagonism of the antiavoidance effects of various agents by anticholinergic drugs.
    Hanson HM; Stone CA; Witoslawski JJ
    J Pharmacol Exp Ther; 1970 May; 173(1):117-24. PubMed ID: 4986082
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological and toxicological studies on gamma-(4-methylpiperidino)-p-fluorobutyrophenone (FG 5111)--a new neuroleptic agent.
    Christensen JA; Hernestam S; Lassen JB; Sterner N
    Acta Pharmacol Toxicol (Copenh); 1965; 23(2):109-32. PubMed ID: 5899275
    [No Abstract]   [Full Text] [Related]  

  • 13. The conformation of neuroleptic drugs.
    Koch MH
    Mol Pharmacol; 1974 May; 10(3):425-37. PubMed ID: 4854690
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the accumulation of O-methylated dopamine and noradrenaline in the rat brain following various neuroleptics, thymoleptics and aceperone.
    Scheel-Krüger J
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):372-8. PubMed ID: 5015941
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic drugs and the central dopaminergic system. Antagonism between L-dopa and some butyrophenones on the EEG and motor effects elicited by stimulation of the mesencephalon in the rabbit.
    Florio V; Longo VG
    Neuropharmacology; 1971 Jan; 10(1):45-54. PubMed ID: 5569306
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of psychoactive drugs on conflict avoidance behavior in human subjects.
    Lehmann HE; Ban TA
    Act Nerv Super (Praha); 1971; 13(2):82-5. PubMed ID: 5145599
    [No Abstract]   [Full Text] [Related]  

  • 17. Infantile shock traumatization and the mitigating effects of tranquilizing drugs.
    Gauron EF; Rowley VN
    J Genet Psychol; 1967 Dec; 111(2d Half):263-70. PubMed ID: 5586512
    [No Abstract]   [Full Text] [Related]  

  • 18. Aroylpiperidines and pyrrolidines. A new class of potent central nervous system depressants.
    Duncan RL; Helsley GC; Welstead WJ; DaVanzo JP; Funderburk WH; Lunsford CD
    J Med Chem; 1970 Jan; 13(1):1-6. PubMed ID: 5460893
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between antiavoidance activities of antipsychotic drugs in rats and daily clinical doses.
    Kuribara H; Tadokoro S
    Pharmacol Biochem Behav; 1981 Feb; 14(2):181-92. PubMed ID: 6111088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditioning of food aversions by injections of psychoactive drugs.
    Berger BD
    J Comp Physiol Psychol; 1972 Oct; 81(1):21-6. PubMed ID: 5074304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.